PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences

SOUTH PLAINFIELD, N.J., Feb. 16, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences:

Raymond James 42nd Annual Institutional Investors Conference Tuesday, March 2nd at 7:30 a.m. ET

Cowen 41st Annual Health Care ConferenceThursday, March 4th at 10:30 a.m. ET 

Barclays Global Healthcare ConferenceWednesday, March 10th at 9:10 a.m. ET

The presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

For More Information Please Contact:

Media & Investors:                                                           Jane Baj                                                         +1 (908) 912-9167                                      [email protected]                                        

View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-virtual-investor-conferences-301227815.html

SOURCE PTC Therapeutics, Inc.